Biosensics

Biosensics is a pioneering private company in the wearable medical device and digital health space, with over 17 years of research and development. Its core business is providing validated wearable sensor technologies and digital platforms to pharmaceutical companies and researchers for objective endpoint measurement in clinical trials, particularly in neurology and rare diseases. The company operates on a B2B model, generating revenue through product sales and services, and leverages strong academic-industry partnerships for research and commercialization. While financially opaque as a private entity, its established product use in trials and with older adults suggests it is a revenue-generating company.

Wearable sensor-based platform (inertial sensors) and digital software for capturing, processing, and analyzing movement data to create validated digital biomarkers for objective assessment of disease symptoms and functional outcomes.

Biosensics competes in the digital biomarker and clinical trial technology space against large medtech firms (e.g., Medtronic, Philips), specialized digital health companies (e.g., ActiGraph, MC10), and tech giants (e.g., Apple, Google) exploring health applications. Its differentiation lies in its long-term focus on clinical validation in neurology and rare diseases.